The Trump administration on Monday announced new Medicaid drug pricing agreements with nine midsize biotechnology and pharmaceutical companies. Every drug “will be at the lowest prices available anywhere in the world,” President Trump said…
Page F4From§Eachthe supper edition — 31 August 2026
Administration announces nine drug-price deals, then re-announces same nine deals as a Medicaid win.
As it ran on the front
The filing shows nine deals. The Washington Examiner's account shows nine deals. The Hill's account shows nine deals with nine firms. Running the two against each other, the count matches: nine and nine. What does not match is the label.
In the first telling, the nine deals lower prescription prices under most-favored-nation pricing, the number cited without a program attached. In the second telling, the same nine deals are affixed to Medicaid, a program serving low-income and disabled beneficiaries, filed the same week.…
…(cont) This is not a discrepancy in arithmetic. Nine times, nine times, the number holds. It is a discrepancy in packaging: one announcement for the wire generally, one announcement for the population that polls worst on this administration's approval, filed close enough together that a beneficiary checking two outlets could reasonably believe two different sets of savings had arrived, when the ledger records one.
We called this reconciled. Nine deals, one set of price agreements, two press cycles, hon.
Ask where the second cycle was aimed. Medicaid enrollment skews toward the population an administration most needs to reach ahead of a midterm year, and a second announcement of the identical deal, timed to land on that program by name, is a communications expense that shows up nowhere in a drug-savings ledger. It shows up in a media budget instead.
None of this changes what the nine deals do. Nine agreements with nine manufacturers on price is nine agreements with nine manufacturers on price, and the savings, if realized, land the same whether the release says 'most-favored-nation' or 'Medicaid.' What changes is who was told twice, and why the count needed to be said twice to land once.
The gap here is not in the deals. It's in the announcing. And that gap, filed twice, in two different papers, in one week, is exactly the size of an election cycle. We note it and move on, the way this desk moves on from any number that adds up correctly and still doesn't sit right.
“Same nine deals, told twice, once quiet and once with 'Medicaid' stapled on for the cameras — that's not a savings plan, that's a mailer. You don't announce arithmetic twice unless you need two audiences to believe it happened separately.”
“Reannouncing the deal for Medicaid isn't spin, it's outreach — patients deserve to hear good news in language that applies to them. Not that it's the same news dressed— no, it's the same deal, obviously, we said that upfront. We did say that upfront.”
The receipts
The Trump administration announced nine new drug price reduction deals with midsize pharmaceutical companies in an effort to continue lowering prescription drug costs ahead of the November midterm elections. President Donald Trump said…
This page is a back-issue: the story as it ran, receipts as they were. The current edition is at the front.